Early high-throughput transcriptome data analysis found that MIAC was differentially expressed in other four tumors, including thyroid cancer, prostate cancer, lung adenocarcinoma, and colon adenocarcinoma. This evidence concerns the gene AQP5-AS1 and lung adenocarcinoma.